In Brief: GMPs for finished pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
GMPs for finished pharmaceuticals: FDA extends until Sept. 30 the deadline for comment on a proposed rule published May 3 that would clarify certain manufacturing, quality control and documentation requirements for current Good Manufacturing Practices for finished forms of pharmaceuticals, the agency announces in the July 29 Federal Register. FDA granted the extension in response to a request from the Nonprescription Drug Manufacturers Association...